A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

ClinicalTrials.gov ID: NCT07169851

Public ClinicalTrials.gov record NCT07169851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease

Study identification

NCT ID: NCT07169851
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 204 participants

Conditions and interventions

Conditions

Interventions

Background Chemotherapy Drug
LY3537021 Drug
Placebo Drug
Standard of Care Antiemetic Therapies Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 27, 2025
Primary completion: Nov 30, 2026
Completion: Jan 31, 2027
Last update posted: Apr 21, 2026

2025 – 2027

United States locations

U.S. sites: 18
U.S. states: 12
U.S. cities: 18

Facility	City	State	ZIP	Site status
Marin Cancer Care	Greenbrae	California	94904	Recruiting
City of Hope Orange County Lennar Foundation Cancer Center	Irvine	California	92618	Not yet recruiting
Cancer and Blood Specialty Clinic	Los Alamitos	California	90720	Recruiting
BASS Cancer Center	Walnut Creek	California	94598	Recruiting
UCHealth Harmony	Fort Collins	Colorado	80528	Recruiting
Clavis Medical	Miami Lakes	Florida	33014	Recruiting
BRCR Global - Tamarac	Tamarac	Florida	33321	Recruiting
Summit Cancer Care, PC	Savannah	Georgia	31405	Recruiting
Hope and Healing Cancer Services	Hinsdale	Illinois	60521	Recruiting
North Mississippi Hematology and Oncology Associates	Tupelo	Mississippi	38801	Recruiting
Laura and Isaac Perlmutter Cancer Center	New York	New York	10016	Recruiting
Oncology Specialists of Charlotte	Charlotte	North Carolina	28207	Recruiting
Southern Oncology Specialists	Huntersville	North Carolina	28078	Recruiting
Asante Rogue Regional Medical Center	Medford	Oregon	97504	Recruiting
World Research Link	Baytown	Texas	77521	Recruiting
John Peter Smith Hospital	Fort Worth	Texas	76104	Recruiting
Community Cancer Trials of Utah	Ogden	Utah	84405	Recruiting
Cancer Care Northwest	Spokane	Washington	99202	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07169851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 21, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07169851 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →